Gerber is Voluntarily Recalling Two Batches of GERBER® Organic 2ND FOODS® Pouches Due to a Packaging Defect That May Result in Product Spoilage

Gerber Products Company is voluntarily recalling specific Organic pouch products after identifying a packaging defect that may result in product spoilage during transport and handling. Because of our commitment to high quality, Gerber is working to retrieve from retailers and online stores the remaining pouches from the four affected batches of GERBER® Organic 2ND FOOD pouches that fail to meet our quality standards. We are offering replacement coupons for consumers who purchased the following products:

FDA takes important step to increase the development of, and access to, abuse-deterrent opioids

The U.S. Food and Drug Administration today issued a draft guidance intended to support industry in their development of generic versions of approved opioids with abuse-deterrent formulations (ADF) while ensuring that generic ADF opioids are no less abuse-deterrent than the brand-name drug.

FDA approves Cinqair to treat severe asthma

The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.